Segmentectomy for Lung Adenocarcinoma: The Impact of EGFR Mutation Status on Recurrence

被引：0
|
作者：
Hyun, K. [1 ]
Park, S. [1 ]
Lee, H. J. [1 ]
Park, I. K. [2 ]
Kim, Y. [2 ]
Kang, C. H. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Thorac & Cardiovasc Surg, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
segmentectomy; EGFR; Adenocarcinoma;
D O I：
10.1016/j.jtho.2017.09.1828
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.16-022
引用
收藏
页码：S2351 / S2351
页数：1
相关论文
共 50 条
  • [41] Pre-Chemotherapy EGFR Mutation Status Et Outcomes with Second Line Gefitinib in Advanced Adenocarcinoma Lung
    Karpe, Ashay
    Noronha, Vanita
    Patil, Vijay
    Joshi, Amit
    Chougule, Anuradha
    Janu, Amit
    More, Sucheta
    Goud, Supriya
    Ramaswamy, Anant
    Pande, Nikhil
    Chandrasekharan, Arun
    Goel, Alok
    Talreja, Vikas
    Prabhash, Kumar
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1516 - S1516
  • [42] Predicting EGFR mutation status in lung adenocarcinoma: development and validation of a computed tomography-based radiomics signature
    Zhang, Guojin
    Cao, Yuntai
    Zhang, Jing
    Ren, Jialiang
    Zhao, Zhiyong
    Zhang, Xiaodi
    Li, Shenglin
    Deng, Liangna
    Zhou, Junlin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (02): : 546 - +
  • [43] Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma
    Okada, Morihito
    Mimae, Takahiro
    Tsutani, Yasuhiro
    Nakayama, Haruhiko
    Okumura, Sakae
    Yoshimura, Masahiro
    Miyata, Yoshihiro
    ANNALS OF CARDIOTHORACIC SURGERY, 2014, 3 (02) : 153 - 159
  • [44] POSTRECURRENCE SURVIVAL OF SURGICALLY RESECTED PULMONARY ADENOCARCINOMA PATIENTS ACCORDING TO EGFR AND KRAS MUTATION STATUS
    Ohtaki, Yoichi
    Shimizu, Kimihiro
    Kakegawa, Seiichi
    Nagashima, Toshiteru
    Obayashi, Kai
    Nakano, Tetsuhiro
    Atsumi, Jun
    Igai, Hitoshi
    Ibe, Takashi
    Sugano, Masayuki
    Kamiyoshihara, Mitsuhiro
    Kawashima, Osamu
    Kaira, Kyoichi
    Takeyoshi, Izumi
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1119 - S1120
  • [45] MUTATION STATUS OF EGFR, K-RAS AND P53 IN SORTED ADENOCARCINOMA CELLS
    Kaneda, Hiroyuki
    Nakano, Takahito
    Saito, Tomohito
    Minami, Kenichiro
    Konobu, Toshifumi
    Saito, Yukihito
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S950 - S950
  • [46] Anterior gradient 2 is correlated with EGFR mutation in lung adenocarcinoma tissues
    Narumi, Sodai
    Miki, Yasuhiro
    Hata, Shuko
    Ebina, Masahito
    Saito, Mikiyoshi
    Mori, Kazushige
    Kobayashi, Makoto
    Suzuki, Takashi
    Iwabuchi, Erina
    Sato, Ikuro
    Maemondo, Makoto
    Endo, Chiaki
    Inoue, Akira
    Kondo, Takashi
    Yamada-Okabe, Hisafumi
    Ichinose, Masakazu
    Sasano, Hironobu
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (02) : E234 - E242
  • [47] Predictive radiogenomics modeling of EGFR mutation status in lung cancer
    Gevaert, Olivier
    Echegaray, Sebastian
    Khuong, Amanda
    Hoang, Chuong D.
    Shrager, Joseph B.
    Jensen, Kirstin C.
    Berry, Gerald J.
    Guo, H. Henry
    Lau, Charles
    Plevritis, Sylvia K.
    Rubin, Daniel L.
    Napel, Sandy
    Leung, Ann N.
    SCIENTIFIC REPORTS, 2017, 7
  • [48] EGFR activating mutation in lung adenocarcinoma: Risk factor of thromboembolic event?
    Noel-Savina, E.
    Paleiron, N.
    Le Gal, G.
    Descourt, R.
    REVUE DES MALADIES RESPIRATOIRES, 2012, 29 (09) : 1137 - 1140
  • [49] Differential Prognostic Effect of EGFR Mutation According to Smoking Status and Pathologic Stage in Non-mucinous Lung Adenocarcinoma
    Lee, J.
    Yoon, S. H.
    Shih, B.
    Jung, W.
    Hwang, Y.
    Jeon, J. H.
    Cho, S.
    Kim, K.
    Jheon, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S604 - S604
  • [50] Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma
    Zhang, Ping
    Wu, Xiaonan
    Tang, Min
    Nie, Xin
    Li, Lin
    THORACIC CANCER, 2019, 10 (12) : 2218 - 2224
12345